← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Tarn Biosciences, Inc.
East Lansing, MI
$889,203
Total funding
2
Grants
Funding over time
peak $298.8K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$889,203 · 2
By mechanism
R41$889,203 · 2
Investigators at Tarn Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of nitroreductase-activated inhibitors to treat mycobacterial infections$298,829
R41 · FY2025 · AI
Development of the HC2099 series of MmpL3 inhibitors to treat tuberculosis$297,136
R41 · FY2023 · AI
Development of the HC2099 series of MmpL3 inhibitors to treat tuberculosis$293,238
R41 · FY2024 · AI